LISA TIEBAUER: Open Payments
NPI 1700069044 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,797 in 225 payments from 15 companies in 2025. Trend: 2023 $333 · 2024 $2,215 · 2025 $2,797
Food & beverage: $2,790Education: $8
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 23 | $361 |
| E.R. Squibb & Sons, L.L.C. | 24 | $336 |
| Vanda Pharmaceuticals Inc. | 19 | $289 |
| ABBVIE INC. | 28 | $271 |
| Otsuka America Pharmaceutical, Inc. | 27 | $269 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $264 |
| Lundbeck LLC | 13 | $226 |
| Neurocrine BioSciences, Inc. | 18 | $197 |
| Teva Pharmaceuticals USA, Inc. | 25 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $138 |
Products named: REXULTI, COBENFY, ARISTADA, HETLIOZ, VRAYLAR, CAPLYTA, INGREZZA, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
